MREO

Rosen Law Firm reminds investors of Mereo BioPharma about a securities fraud class action lawsuit. The class period is from June 5, 2023, to December 26, 2025. Investors who purchased Mereo ADS during this period and suffered losses exceeding $100,000 have the opportunity to lead the case.

AI-generated: summaries written by AI from the linked sources. How we use AI